Wirostko Barbara 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-02-01+50,000→ 50,000 totalExercise: $0.48Exp: 2029-02-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2020, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.